371 related articles for article (PubMed ID: 37871693)
1. Expert review: preeclampsia Type I and Type II.
Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
[TBL] [Abstract][Full Text] [Related]
2. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
3. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
[TBL] [Abstract][Full Text] [Related]
5. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.
Romero R; Jung E; Chaiworapongsa T; Erez O; Gudicha DW; Kim YM; Kim JS; Kim B; Kusanovic JP; Gotsch F; Taran AB; Yoon BH; Hassan SS; Hsu CD; Chaemsaithong P; Gomez-Lopez N; Yeo L; Kim CJ; Tarca AL
Am J Obstet Gynecol; 2022 Oct; 227(4):615.e1-615.e25. PubMed ID: 36180175
[TBL] [Abstract][Full Text] [Related]
6. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
[TBL] [Abstract][Full Text] [Related]
7. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
[TBL] [Abstract][Full Text] [Related]
8. Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction.
Dymara-Konopka W; Laskowska M; Grywalska E; Hymos A; Błażewicz A; Leszczyńska-Gorzelak B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674486
[TBL] [Abstract][Full Text] [Related]
9. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
10. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
11. The additive role of angiogenic markers for women with confirmed preeclampsia.
Suresh S; Patel E; Mueller A; Morgan J; Lewandowski WL; Verlohren S; von Dadelszen P; Magee LA; Rana S
Am J Obstet Gynecol; 2023 May; 228(5):573.e1-573.e11. PubMed ID: 36356699
[TBL] [Abstract][Full Text] [Related]
12. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
13. High early pregnancy body mass index is associated with alterations in first- and second-trimester angiogenic biomarkers.
Beck C; Allshouse A; Silver RM; Grobman WA; Simhan H; Haas D; Reddy UM; Blue NR
Am J Obstet Gynecol MFM; 2022 May; 4(3):100614. PubMed ID: 35283347
[TBL] [Abstract][Full Text] [Related]
14. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
[TBL] [Abstract][Full Text] [Related]
16. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia.
Staff AC; Fjeldstad HE; Fosheim IK; Moe K; Turowski G; Johnsen GM; Alnaes-Katjavivi P; Sugulle M
Am J Obstet Gynecol; 2022 Feb; 226(2S):S895-S906. PubMed ID: 32971013
[TBL] [Abstract][Full Text] [Related]
17. Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35-37 weeks of gestation.
Garcia-Gonzalez C; Abdel-Azim S; Galeva S; Georgiopoulos G; Nicolaides KH; Charakida M
Am J Obstet Gynecol; 2020 Jun; 222(6):604.e1-604.e10. PubMed ID: 31954157
[TBL] [Abstract][Full Text] [Related]
18. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
[TBL] [Abstract][Full Text] [Related]
19. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction.
Gaccioli F; Sovio U; Gong S; Cook E; Charnock-Jones DS; Smith GCS
Hypertension; 2023 Feb; 80(2):325-334. PubMed ID: 35866422
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia.
Westerberg AC; Degnes ML; Andresen IJ; Roland MCP; Michelsen TM
Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38494070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
